Claims for Patent: 8,334,324

Summary for Patent: 8,334,324

Title:	Films and particles
Abstract:	Described herein are compounds and processes that can be used to prepare polymer-based films, particles, gels and related compositions, and processes for delivery of agents, and other uses.
Inventor(s):	Colson; Yolonda L. (Dover, MA), Azouz; Solomon (Dallas, TX), Grinstaff; Mark W. (Brookline, MA), Wolinsky; Jesse (Brookline, MA), Griset; Aaron (Medford, MA)
Assignee:	The Trustees of the Boston University (Boston, MA) The Brigham and Women\'s Hospital, Inc. (Boston, MA)
Application Number:	12/690,607
Patent Claims:	1. An oligomer or polymer having a repeat unit represented by formula: ##STR00083## 2. The oligomer or polymer of claim 1 comprising 2-750 monomeric units and wherein the oligomeric or polymeric chain has a terminal group being selected from among amines, thiols, amides, phosphates, sulphates, hydroxides, alkenes and alkynes. 3. A composition comprising the oligomer or polymer of claim 1. 4. A polymeric film or particle comprising an oligomer or polymer of claim 1. 5. A polymeric particle of claim 4, comprising a microparticle or nanoparticle. 6. A polymeric particle of claim 5, wherein the particle has a diameter between about 2 nm and 1 micron. 7. The polymeric particle of claim 5 comprising a first volume at a first pH, and a second volume at a second pH, different from the from the first pH. 8. The polymeric particle of claim 7, wherein the second volume is 1.times. or more greater than the first volume when the second pH is lower than the first pH. 9. The polymeric particle of claim 7, wherein the second volume is 4.times. or more greater than the first volume when the second pH is lower than the first pH. 10. The polymeric particle of claim 7, wherein the second volume is 8.times. or more greater than the first volume when the second pH is lower than the first pH. 11. The polymeric particle of claim 7, wherein the second volume is greater than the first volume and the change in volume is sufficient that the particle when within a cell during the volume change ruptures the cell or a cellular compartment. 12. The polymeric particle of claim 7, wherein the second volume is greater than the first volume and the change in volume is sufficient to cause the particle to become lodged, embedded, or immobilized in an anatomic location selected from a lymph node, airway, cavity, capillary, or other tissue. 13. The polymeric film or particle of claim 4, further comprising an agent. 14. The polymeric film or particle of claim 13, wherein the agent is a biologically active agent comprising one or more of an anti-cancer agent, an anti-biotic, an anti-neoplastic agent, an analgesic, an angiogenic, or an agent that promotes wound healing. 15. The polymeric film or particle of claim 13, wherein the biologically active agent comprises one or more of asparaginase; bleomycin; busulfan; capecitabine; carboplatin; carmustine chlorambucil; cisplatin; cyclophosphamide; cytarabine; dacarbazine; dactinomycin; daunorubicin; dexrazoxane; docetaxel; doxorubicin; etoposide; floxuridine; fludarabine; fluorouracil; gemcitabine; hydroxyurea; idarubicin; ifosfamide; irinotecan; lomustine; mechlorethamine; melphalan; mercaptopurine; methotrexate; mitomycin; mitotane; mitoxantrone; paclitaxel; pemetrexed; pentostatin; plicamycin; procarbazine; rituximab; streptozocin; teniposide; thioguanine; thiotepa; vinblastine; vincristine; and vinorelbine. 16. The film of claim 4, wherein the film is a single layered film. 17. The film of claim 13, further comprising two or more layers to form a multi-layered film. 18. The film of claim 13, comprising a first layer comprising a first polymer of formula ##STR00084## and a second layer comprising a second polymer different from the first polymer. 19. The film of claim 18, wherein the second polymer comprises one or more of poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic acid), polycaprolactone, poly(trimethlene carbonate), polyester, polycarbonate, and polyimide.

Details for Patent 8,334,324

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2026-05-31
Genentech, Inc.	RITUXAN	rituximab	Injection	103705	11/26/1997		2026-05-31
Idec Pharmaceuticals Corp.	RITUXAN	rituximab	Injection	103737	02/19/2002		2026-05-31
Genentech, Inc.	RITUXAN HYCELA	rituximab and hyaluronidase human	Injection	761064	06/22/2017		2026-05-31